A recent episode of BioTechNation features Dr. David Bearss, CEO of Halia Therapeutic. Bearss discusses inflammation and unveils the potential of the inflammasome in treating diseases where inflammation plays a critical role, such as Alzheimers.
BioTech Nation Podcast: Fighting Inflammation, and Alzheimer’s: Dr. David Bearss, President & CEO Halia Therapeutics
